Similar articles

• Bacteremia due to Pseudomonas aeruginosa: use of a combined typing system in an eight-year study.

  Conroy JV, Baltch AL, Smith RP, Hammer MC, Griffin PE. Conroy JV, et al. J Infect Dis. 1983 Sep;148(3):603. doi: 10.1093/infdis/148.3.603. J Infect Dis. 1983. PMID: 6413597
• Pseudomonas aeruginosa vasculitis and bacteremia following conjunctivitis: a simple model of fatal pseudomonas infection in neutropenia.

  Ziegler EJ, Douglas H. Ziegler EJ, et al. J Infect Dis. 1979 Mar;139(3):288-96. doi: 10.1093/infdis/139.3.288. J Infect Dis. 1979. PMID: 109545
• Evaluation of type-specific and non-type-specific pseudomonas vaccine for treatment of pseudomonas sepsis during granulocytopenia.

  Harvath L, Andersen BR. Harvath L, et al. Infect Immun. 1976 Apr;13(4):1139-43. doi: 10.1128/iai.13.4.1139-1143.1976. Infect Immun. 1976. PMID: 819373 Free PMC article.
• [Pseudomonas aeruginosa. Application of serotyping and pyocin typing to strains isolated in Algeria].

  Kezzal K, Rahal K. Kezzal K, et al. Arch Inst Pasteur Alger. 1986;55:61-77. Arch Inst Pasteur Alger. 1986. PMID: 3152815 Review. French. No abstract available.
• Septic complications of procainamide-induced agranulocytosis: report of two cases.

  Freed JS, Reiner MA. Freed JS, et al. Mt Sinai J Med. 1988 Mar;55(2):194-7. Mt Sinai J Med. 1988. PMID: 3290673 Review. No abstract available.